ANNUAL REPORT 2016-2017

INTRODUCTION

A TIME FOR BOLDNESS IN GLOBAL HEALTH

Unitaid takes inspiration from the idea that we are all part of the human family and that no single country can view the well-being of its own people in isolation from others...

READ MORE

UNLEASHING A WAVE OF HEALTH INNOVATION

Rarely have the odds looked better for ridding the world of HIV/AIDS, tuberculosis, malaria and other deadly infectious diseases...

READ MORE

WHAT WE DO

Unitaid invests in new ways to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, affordably and effectively. We also work to improve access to diagnostics and treatment for HIV co-infections including hepatitis C. We bring the power of new medical discoveries to the people who most need them. Unitaid helps set the stage for the large-scale introduction of new health products. We do this by collaborating with governments, industry, technical agencies, civil society and funding partners.

OUR NEW STRATEGY

Unitaid adopted a strategy for 2017 to 2021 to support global efforts to end HIV/AIDS, malaria and tuberculosis, and to help reduce inequality in access to healthcare.

Unitaid’s strategic objectives are to foster innovation and create the right conditions for mass introduction of pioneering medicines, diagnostic tests and prevention tools. The strategy follows the Sustainable Development Goal on health, which sets out to promote access to healthcare as a basic human right over the next 15 years.

Unitaid collaborates with global health partners and governments to:

IDENTIFY

shortcomings in the global response.

SEARCH FOR

smart new ideas to help close the gaps.

CHOOSE

the best proposals and fund their development.

ACCELERATE

full-scale deployment of practical solutions.

QUICK FACTS ABOUT UNITAID

Portfolio

July 2017



47 GRANTS
US$ 1,011 MILLION
  • HIV

  • TB

  • Malaria

  • Cross-cutting

Our donors

Unitaid’s current donors are France, the United Kingdom, Brazil, Norway, Chile, the Republic of Korea, Spain and the Bill & Melinda Gates Foundation. A key source of income is innovative financing, specifically the international solidarity levy on airline tickets.

  • Cumulative contributions of top eight donors since inception (2006 - 2016) In m of US$
  • France 1,605.4
  • United Kingdom of Great Britain and Northern Ireland 607.3*
  • Norway 183.0
  • Bill & Melinda Gates Foundation 100.0
  • Brazil 90.3
  • Spain 81.6
  • Republic of Korea 51.0
  • Chile 33.5
  • Others** 20.8

* Includes £88 m of promissory notes translated to US$107.7 m as of 31.12.2016.

**Includes contributions from Cameroon, Democratic Republic of Congo, Guinea, Luxembourg, Madagascar, Mali, Mauritius and Niger.